Moxonidine
- Generic Name
- Moxonidine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C9H12ClN5O
- CAS Number
- 75438-57-2
- Unique Ingredient Identifier
- CC6X0L40GW
- Background
Moxonidine is a new-generation centrally acting antihypertensive drug approved for the treatment of mild to moderate essential hypertension. It is suggested to be effective in cases where other agents such as thiazides, beta-blockers, ACE inhibitors, and calcium channel blockers are not appropriate or irresponsive. As well, moxonidine has been shown to prese...
- Indication
For the treatment of mild to moderate essential or primary hypertension . Effective as most first-line antihypertensives when used as monotherapy .
- Associated Conditions
- Hypertension
- Associated Therapies
- -
Moxonidine in Patients Undergoing Vascular Surgery
- First Posted Date
- 2005-10-26
- Last Posted Date
- 2009-11-10
- Lead Sponsor
- University Hospital, Basel, Switzerland
- Target Recruit Count
- 141
- Registration Number
- NCT00244504
- Locations
- 🇨🇭
University hospital, Basel, CH, Switzerland
Efficacy and Safety of Moxonidine in Indian Patients
- Conditions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2009-01-30
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 100
- Registration Number
- NCT00160277
- Locations
- 🇮🇳
Site 3, New Delhi, India
🇮🇳Site 1, Jubillee Hills Hyderabad, India
🇮🇳Site 2, Mangalore, India
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.